Cellular Highways News Today

New company created to enable commercial manufacture of new cell and gene therapies Cellular Origins' proprietary technology will address current barriers associated with cost-effective and

New company created to enable commercial manufacture of new cell and gene therapies.

Karl Tomusk Bruntwood SciTech has expanded into the UK’s ‘golden triangle’ of elite research universities, acquiring a £46.2m long leasehold of Melbourn Science Park in Cambridge from tech and product development company TTP. The deal will see Legal & General and Bruntwood, the joint venture partners behind Bruntwood SciTech, form a strategic partnership with TTP and work with the local planning authority to develop a masterplan for the 16.4-acre site. Launched in 2018, Bruntwood SciTech...